A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 12, 2004, Pages 4907-4910

  Carter, George ^a   Young, Lowell S ^a   Bermudez, Luiz E ^a,b  

^a Kuzell Institute for Arthritis and Infectious Diseases   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; MOXIFLOXACIN;

AIRWAY; ANTIBACTERIAL ACTIVITY; ARTICLE; BIOFILM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SENSITIVITY; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; AZITHROMYCIN; BIOFILMS; CLARITHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; QUINOLINES;

EID: 9644300994     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.12.4907-4910.2004     Document Type: Article

References (23)

1. Aksamit, T. R. 2002. Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease. Clin. Chest Med. 23:643-653.
2. Bermudez, L. E., C. B. Inderlied, P. Kolonoski, M. Petrofsky, P. Aralar, M. Wu, and L. S. Young. 2001. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium. Antimicrob. Agents Chemother. 45:217-222.
3. Bermudez, L. E., C. B. Inderlied, P. Kolonoski, M. Wu, P. Aralar, and L. S. Young. 2001. Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment. Antimicrob. Agents Chemother. 45:2210-2214.
4. Bermudez, L. E., A. Parker, and J. R. Goodman. 1997. Growth within macrophages increases the efficiency of Mycobacterium avium in invading other macrophages by a complement receptor-independent pathway. Infect. Immun. 65:1916-1925.
5. Bermudez, L. E., M. Petrofsky, P. Kolonoski, and L. S. Young. 1998. Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy. Antimicrob. Agents Chemother. 42:180-183.
6. Bermudez, L. E., M. Wu, E. Miltner, and C. B. Inderlied. 1999. Isolation of two subpopulations of Mycobacterium avium within human macrophages. FEMS Microbiol. Lett. 178:19-26.
7. Brown, M., D. G. Allison, and P. Gilber. 1988. Resistance of bacterial biofilms to antibiotics: a growth rate related effect? J. Antimicrob. Chemother. 22:777-783.
8. Carson, L. A., N. J. Petersen, M. S. Favero, and S. M. Aguero. 1978. Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants. Appl. Environ. Microbiol. 36:839-846.
9. Carter, G., M. Wu, D. C. Drummond, and L. E. Bermudez. 2003. Characterization of biofilm formation by clinical isolates of Mycobacterium avium. J. Med. Microbiol. 52:747-752.
10. Ebert, D. L., and K. N. Olivier. 2002. Nontuberculous mycobacteria in cystic fibrosis. Infect. Dis. Clin. N. Am. 16:221-233.
11. Falkinham, J. O., III. 1996. Epidemiology of infection by nontuberculous mycobacteria. Clin. Microbiol. Rev. 9:177-215.
12. Falkinham, J. O., III, C. D. Norton, and M. W. LeChevallier. 2001. Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare, and other mycobacteria in drinking water distribution systems. Appl. Environ. Microbiol. 67:1225-1231.
13. Haas, C. N., and M. M. Paller. 1983. The ecology of acid-fast organisms in water supply treatment and distribution system. J. Am. Water Work Assoc. 75:139-144.
14. Inderlied, C. B., C. A. Kemper, and L. E. Bermudez. 1993. The Mycobacterium avium complex. Clin. Microbiol. Rev. 6:266-310.
15. Inderlied, C. B., L. S. Young, and J. K. Yamada. 1987. Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods. Antimicrob. Agents Chemother. 31:1697-1702.
16. Mah, T. F., B. Pitts, B. Pellock, G. C. Walker, P. S. Stewart, and G. A. O'Toole. 2003. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426:306-310.
17. Prince, D. S., D. D. Peterson, R. M. Steiner, J. E. Gottlieb, R. Scott, H. L. Israel, W. G. Figueroa, and J. E. Fish. 1989. Infection with Mycobacterium avium complex in patients without predisposing conditions. N. Engl. J. Med. 321:863-868.
18. Recht, J., A. Martinez, S. Torello, and R. Kolter. 2000. Genetic analysis of sliding motility in Mycobacterium smegmatis, J. Bacteriol. 182:4348-4351.
19. Rosenzweig, D. Y. 1979. Pulmonary mycobacterial infections due to Mycobacterium intracellulare-avium complex. Clinical features and course in 100 consecutive cases. Chest 75:115-119.
20. Schulze-Robbecke, R. F. R. 1989. Mycobacteria in biofilms. Zentbl. Hyg Umweltmed. 188:385-390.
21. Wallace, R. J., Jr., B. A. Brown, D. E. Griffith, W. M. Girard, and D. T. Murphy. 1996. Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. Am. J. Respir. Crit. Care Med. 153: 1766-1772.
22. Walters, M. C., III, F. Roe, A. Bugnicourt, M. J. Franklin, and P. S. Stewart. 2003. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother. 47:317-323.
23. Wolinsky, E. 1979. Nontuberculous mycobacteria and associated diseases. Am. Rev. Respir. Dis. 119:107-159.